Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.20.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income (Loss) $ (3,418,632) $ (420,279)
cash provided by (used by) operating activities:    
Depreciation and amortization 23,113 20,762
Non-cash amortization on right of use assets 55,493 0
(Gain) loss on equipment disposal 0 2,738
Bad debt expense 808,241 63,529
Amortization of discount on investment in account receivable (79,994) (79,156)
Change in accrued interest income (8,015) 1,678
(Gain) loss on investment in securities, at fair value 76,395 62,322
(Gain) loss on long-term investments 0 (86,307)
Impairment of G Farma investments 1,688,825 0
Decrease (increase) in operating assets    
Cash in attorney trust account 0 314,536
Finance leases receivable 26,801 (334,482)
Deposits on equipment 27,231 (43,907)
Accounts receivable - trade (127,337) (56,239)
Prepaid expenses and other current assets 644 (33,522)
Employee advances (417) 9,679
Increase (decrease) in operating liabilities    
Accounts payable 6,665 7,195
Accrued expenses (141,804) 134,647
Deferred revenue (15,525) 86,461
Accrued salary, retirement and benefits - related party 81,320 57,637
Net cash provided by (used by) operating activities (996,996) (292,708)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from receivable - Bhang Corporation 0 1,987,099
Purchase of investment securities 0 (236,272)
Proceeds from securities sold 286,190 0
Purchase of convertible notes receivable 0 (50,000)
Proceeds from convertible notes receivable 0 27,561
Advances on notes receivable (31,000) (179,000)
Proceeds from notes receivable 7,298 34,844
Investment in direct financing lease equipment 0 (1,202,799)
Purchase of contractual interest in legal recovery (146,195) (200,000)
Purchases of property and equipment (11,765) (25,740)
Down payment on right of use assets (24,032) 0
Proceeds from sale of investment in Brighter Day Health 0 109,000
Purchase of long-term investments 0 (15,669)
Proceeds from investment in receivable 230,000 117,000
Net cash provided by (used by) investing activities 310,496 366,024
CASH FLOWS FROM FINANCING ACTIVITIES:    
Warrants converted to common stock, net of costs 0 629,205
Payments to rescind Bhang owners' common stock 0 (228,150)
Issuance of Series Q preferred shares, net of costs 0 109,985
Short term loan from related party 0 40,000
Payments on short term loan from related party (12,528) 0
Payments on finance lease liability (28,207) 0
Proceeds from long-term debt 0 50,000
Payments on long-term debt (54,204) (34,438)
Non-controlling interest distribution (2,524) (3,534)
Net cash provided by (used by) financing activities (97,463) 563,068
Net change in cash (783,963) 636,384
Beginning cash 1,470,574 834,190
Ending cash 686,611 1,470,574
SUPPLEMENTARY INFORMATION:    
Cash paid for interest 22,975 17,451
Cash paid for income taxes 18,948 20,220
NON-CASH INVESTING AND FINANCING TRANSACTION:    
Right of use assets acquired through operating lease liability 541,865 0
Right of use assets acquired through finance lease liability 182,301 0
Bhang Corporation receivable cancelled by return of Mentor common stock $ 0 $ 228,150